To support emerging precision therapies and improve patient outcomes by increasing access to reliable genomic testing needed to match patients with targete...
ERS Genomics Limited ('ERS') completes licensing agreement with Syngene International, India's leading Contract Research, Development and Manufacturing Org...
Advicenne expanded partnership validates Avanzanite’s execution capabilities and unwavering commitment to the smallest countries in Europe. Avanzani...
Complements Existing Life Sciences and Mass Spectrometry Offerings, Accelerating Protein Biomarker Discovery and Providing Strong Synergy Opportuniti...
Global genomics solutions provider Integrated DNA Technologies (IDT), an operating company in the Life Sciences segment of Danaher Corporation (NYSE:DHR), ...
“This collaboration between Revvity and Element Biosciences seeks to elevate the overall customer experience by providing compelling application-spec...
Proteintech, a global leader in antibodies, immunoassay kits, and recombinant proteins,announced the launch of Multi-rAb Recombinant Secondary Antibodies, ...
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced the completion of the facilit...
UACI is a leading science and tech startup incubator that is directly connected to the University of Arizona. The University of Arizona is renowned for it...
Headquartered in Beijing, China, Sino Biological is the world’s leading provider of mammalian cell-based recombinant proteins, antibodies, and relate...
“Our ongoing partnership with Bayer leverages the full suite of our Twist Biopharma Solutions offering of antibody discovery services to identify the...
With a mission to accelerate the pace of genomics, Integrated DNA Technologies (IDT), a leading provider of differentiated next generation sequencing (NGS)...
Launch of Pin-pointTM base editing reagents improves access to new-generation editing technology Access to the Pin-point system now bridges discovery, p...
“We are thrilled to receive marketing approval for AVT04 in Japan, which will be Alvotech’s second marketed biosimilar,” said Robert Wess...
© 2024 Biopharma Boardroom. All Rights Reserved.
